StockData
BlossomHill Therapeutics, Inc. logo

BlossomHill Therapeutics, Inc. (BLSM) stock

BLSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$14.59−0.54 (-3.57%)

Close on Nov 18, 2026Market cap $37.18MP/E –Yield –

BlossomHill Therapeutics r&d expenses

Research and development expenses are spending on new products and technology.

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$21.36M–
Q2 FY2025Jun 30, 2025$12.53M–

More BlossomHill Therapeutics figures

See a number that looks wrong?